Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal insulin for prevention of delirium after femoral fracture surgery
ACTRN12625000368437Phase 2Not yet recruiting
- Sponsor
- Prince of Wales Hospital
- Start
- Apr 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in delirium comparing Intranasal insulin aspart with Diluent placebo (2 arms). Primary endpoint: Incidence of delirium. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
insulin aspart
03
Conditions
delirium
Beyond the preview
Go deeper on ACTRN12625000368437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000368437.